Oncosia Scientific at EANM 2026: TeLuNa Work Group Meets at the Oncidium Foundation Booth in Vienna

Reconnecting with clients and partners, and opening new collaborations in radiopharmaceutical dosimetry.

Vienna, 27 October 2026 – Oncosia Scientific GmbH, a specialist dosimetry and medical physics partner for nuclear medicine and radiopharmaceutical development, attended the Annual Congress of the European Association of Nuclear Medicine (EANM 2026), held at the Austria Center Vienna from 17 to 21 October 2026. The congress gave the Oncosia team the opportunity to meet existing clients and partners in person and to start conversations with new ones across pharma, CROs and academic nuclear medicine centres.

A highlight of the week was the in-person meeting of the TeLuNa study collaborators, hosted at the booth of the Oncidium Foundation. The group reviewed the progress of the study and agreed on the next steps toward its upcoming milestones. Within TeLuNa (NCT07441837), Oncosia is responsible for site qualification, imaging center setup and dosimetry.

Beyond the TeLuNa meeting, Oncosia used EANM 2026 to reconnect with sponsors, CROs and clinical sites it supports on radiopharmaceutical trials, and to meet new partners interested in its services.

Oncosia thanks everyone who took the time to meet during the congress and looks forward to continuing these conversations in the months ahead.